SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-24-000072
Filing Date
2024-08-08
Accepted
2024-08-08 16:04:45
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20240630.htm   iXBRL 10-Q 946713
2 EX-31.1 a2024-q210xqex311.htm EX-31.1 10775
3 EX-31.2 a2024-q210xqex312.htm EX-31.2 10850
4 EX-32.1 a2024-q210xqex321.htm EX-32.1 4975
5 EX-32.2 a2024-q210xqex322.htm EX-32.2 4974
11 abus-20240630_g1.jpg GRAPHIC 62055
  Complete submission text file 0001447028-24-000072.txt   5266481

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20240630.xsd EX-101.SCH 38197
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20240630_cal.xml EX-101.CAL 40684
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20240630_def.xml EX-101.DEF 181436
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20240630_lab.xml EX-101.LAB 481328
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20240630_pre.xml EX-101.PRE 333884
64 EXTRACTED XBRL INSTANCE DOCUMENT abus-20240630_htm.xml XML 641557
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 241188119
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)